Johnson & Johnson Innovative Medicine considers that the technology is unlikely to be used at this point in the treatment pathway. If NHS organisations wish to consider niraparib for this indication, ...
They discovered sex-specific and stress-dependent changes in brain metabolism: ELS triggered sex-specific alterations in critical metabolic pathways, processes essential for energy production ...
The drug, known as NXP800, works by targeting the heat shock factor 1 (HSF1) pathway, a cellular protective mechanism that is hijacked to support the growth of cancer. The pathway controls the ...
The treatment works by targeting the heat shock factor 1 (HSF1) pathway, a cellular protective mechanism that is hijacked to support the growth of cancer. The pathway controls the production of ...
The drug, NXP800, aims at the heat shock factor 1 (HSF1) pathway, which is a cellular defence mechanism exploited by cancer cells to support their growth. This pathway regulates the production of ...
The drug in question, NXP800, targets the heat shock factor 1 (HSF1) pathway, which is exploited by cancer cells to foster their growth. At the Institute of Cancer Research, London, studies ...